PremiumCompany AnnouncementsANGLE plc Reports Revenue Growth and Strategic Pharma Partnerships in 2024 ANGLE plc to Announce Preliminary 2024 Results with Analyst Webcast ANGLE plc Advances HER2 Assay Development with Promising New Data PremiumCompany AnnouncementsANGLE plc Announces Breakthrough in Cancer Treatment via Parsortix System ANGLE plc’s HER2 Assay Gains Independent Validation at San Antonio Symposium ANGLE plc Showcases New HER2 Assay Developments PremiumCompany AnnouncementsANGLE plc’s Parsortix System Hits 100 Publications Milestone ANGLE plc Pivots to Pharma Services with Promising Outlook ANGLE Inks Deal for Advanced Cancer Sequencing Tech